The global Furosemide market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Furosemide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Furosemide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Furosemide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Furosemide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sanofi Aventis
US Pharm Holdings
Mylan
Sandoz
Hospira
West-Ward Pharms
Ivax Sub Teva Pharms
Emcure Pharms
Sun Pharm Inds

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Injection
Solution
Tablet

Segment by Application
Hospital
Pharmacy
Clinics